A recent phase 2 exploratory trial in oral mucositis reported that dusquetide, a unique innate immune modulator with a mechanism that potentially addresses each of the phases of OM pathophysiology, is able to reduce the duration of severe oral mucositis, as well as reducing the incidence of infection

See also
Stomatitis

References
General sources
Mucositis Resource Center of the MASCC/ISOO Mucositis Study Group. Medical journal articles, guidelines, recommendations, and slides and videos from conference presentations. == External links ==
infection of nose and nasopharynx - 70%
infection of palpebral conjunctiva - 15%

Diagnosis
History
Unilateral nasal obstruction
Epistaxis
Local pruritus
Rhinorrhea
Coryza (rhinitis) with sneezing
Post nasal discharge with cough
Foreign body sensation
History of exposure to contaminated water
Increased tearing and photo phobia in cases of infection of palpebral conjunctiva
On examination
Pink to deep red polyps
Strawberry like appearance
Bleeds easily upon manipulation
Diagnosis
confirmed by biopsy and histopathology - several round or oval sporangia and spores which may be seen bursting through its chitinous wall

Treatment
Surgical excision - wide excision with wide area electro-coagulation of the lesion base
Medical treatment is not so effective but treatment with a year-long course of dapsone has been reported
Recurrence is common

Epidemiology
Disease endemic in Chhattisgarh South India, Sri Lanka, South America and Africa. It is presumed to be transmitted by exposure to the pathogen when taking a bath in stagnant water pools where animals also bathe. References


== External links ==